Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Jan 6;13(1):6-8.
doi: 10.2215/CJN.12021017. Epub 2017 Dec 5.

Lowering Expectations with Niacin Treatment for CKD-MBD

Affiliations
Editorial

Lowering Expectations with Niacin Treatment for CKD-MBD

Tilman B Drüeke et al. Clin J Am Soc Nephrol. .
No abstract available

Keywords: Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bone Disorder; Probability; Renal Insufficiency, Chronic; chronic kidney disease; hyperphosphatemia; mineral metabolism; niacin; nicotinic acid; phosphate binders; phosphate transport inhibitors.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Schematic view of the action of oral inhibitors of active intestinal phosphate absorption compared with the chelation of phosphate in the gut lumen by oral phosphate binders. Modified from reference , with permission.

Comment on

References

    1. Ginsberg C, Ix JH: Nicotinamide and phosphate homeostasis in chronic kidney disease. Curr Opin Nephrol Hypertens 25: 285–291, 2016 - PMC - PubMed
    1. Lenglet A, Liabeuf S, Guffroy P, Fournier A, Brazier M, Massy ZA: Use of nicotinamide to treat hyperphosphatemia in dialysis patients. Drugs R D 13: 165–173, 2013 - PMC - PubMed
    1. Kamanna VS, Kashyap ML: Mechanism of action of niacin. Am J Cardiol 101: 20B–26B, 2008 - PubMed
    1. Bodor ET, Offermanns S: Nicotinic acid: An old drug with a promising future. Br J Pharmacol 153[Suppl 1]: S68–S75, 2008 - PMC - PubMed
    1. Block GA, Rosenbaum DP, Leonsson-Zachrisson M, Åstrand M, Johansson S, Knutsson M, Langkilde AM, Chertow GM: Effect of tenapanor on serum phosphate in patients receiving hemodialysis. J Am Soc Nephrol 28: 1933–1942, 2017 - PMC - PubMed